Medtech

Recursion to Participate in Upcoming Investor Conferences

Retrieved on: 
Friday, March 1, 2024

SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:

Key Points: 
  • SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in the following investor conferences:
    Morgan Stanley Technology, Media and Telecom Conference – March 4-7, 2024
    KeyBanc Emerging Technology Summit – March 5-6, 2024
    Leerink Partners Global Biopharma Conference – March 11-13, 2024
    KeyBanc Life Sciences & MedTech Investor Forum – March 19-20, 2024

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Thursday, February 29, 2024

Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference, which takes place March 12 – 13, 2024.

Key Points: 
  • Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference, which takes place March 12 – 13, 2024.
  • Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver a corporate presentation on Tuesday, March 12, 2024, at 10:40am ET.
  • A webcast of the presentation will be available in the Events section of Nyxoah’s Investor Relations website.
  • Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Wednesday, February 28, 2024

RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

Key Points: 
  • RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.
  • The Company’s virtual presentation will take place on Tuesday, March 12, 2024 at 4:40 pm Eastern Time.
  • The conference webcast will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations.
  • Replays of the webcasts will be archived on the website for approximately 90 days.

Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Wednesday, February 28, 2024

SAN CLEMENTE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

Key Points: 
  • SAN CLEMENTE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.

Charlotte Hanneman to succeed Abhijit Bhattacharya as Philips’ Chief Financial Officer (CFO)

Retrieved on: 
Wednesday, February 28, 2024

The proposal will be submitted to the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024.

Key Points: 
  • The proposal will be submitted to the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024.
  • Ms. Hanneman will join Philips as a member of Philips’ Executive Committee on June 1, 2024, to start her induction and transition into the role, succeeding current CFO Abhijit Bhattacharya on October 1, 2024.
  • In this current role, she is responsible for financial control, enterprise financial planning and analysis, and business development finance.
  • I am fully focused on delivering on Philips’ plan in the next six months and ensuring a seamless handover to Charlotte.”

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Retrieved on: 
Tuesday, February 27, 2024

CARMEL, Ind., Feb. 27, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that President and Chief Executive Officer Brian Carrico and Chief Medical Officer Dr. Adrian Miranda, will participate in the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 12, 2024.

Key Points: 
  • CARMEL, Ind., Feb. 27, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today announced that President and Chief Executive Officer Brian Carrico and Chief Medical Officer Dr. Adrian Miranda, will participate in the upcoming Oppenheimer 34th Annual Healthcare MedTech & Services Conference on March 12, 2024.
  • NeurAxis will give a corporate presentation on Tuesday, March 12, 2024, at 8:40 am ET and host investor 1x1 meetings, which can be requested through Oppenheimer.
  • To access the live webcast, please visit the investors page of the NeurAxis website.
  • The webcast will also be available for replay on NeurAxis’ investor relations website.

Pulsed Field Ablation Innovator Argá Medtech Announces €54 Million Oversubscribed Series B Capital Raise

Retrieved on: 
Tuesday, February 27, 2024

LAUSANNE, Switzerland and SAN DIEGO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Argá Medtech, a private company developing Coherent Sine-Burst Electroporation™ (CSE™), a next-generation cardiac ablation system for treating cardiac arrhythmias, including atrial fibrillation (AF), today announced the closure of a €54M oversubscribed Series B funding. The round was led by the existing investors, Advent Life Sciences (UK) and Earlybird Health (Germany), as well as new investor Gilde Healthcare (the Netherlands) and an undisclosed strategic investor. The financing enables Argá Medtech to advance the development of its innovative CSE™ Pulsed Field Ablation (PFA) system for treating AF through the execution of an IDE study in the US and a CE Mark study in the EU. With the funding, the company will also expand its US offices in San Diego, CA, in anticipation of its US clinical activities.  

Key Points: 
  • The financing enables Argá Medtech to advance the development of its innovative CSE™ Pulsed Field Ablation (PFA) system for treating AF through the execution of an IDE study in the US and a CE Mark study in the EU.
  • With the funding, the company will also expand its US offices in San Diego, CA, in anticipation of its US clinical activities.
  • “We are pleased to secure the support of such marquee investors who believe that Argá Medtech will revolutionize the atrial fibrillation ablation field,” said David Neale, CEO of Argá Medtech.
  • Argá Medtech’s CSE™ system uses a sinusoidal/sine wave, while other PFA platforms are typically powered by square wave energy sources.

Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report

Retrieved on: 
Monday, February 26, 2024

Framingham, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health , a global life sciences advisory and clinical research firm, announced the release of the 2024 Global Medtech Contract Manufacturing Report .

Key Points: 
  • Framingham, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health , a global life sciences advisory and clinical research firm, announced the release of the 2024 Global Medtech Contract Manufacturing Report .
  • This report offers a comprehensive analysis of trends in the global medtech contract manufacturing (CDMO) market and includes a deep dive into the contract manufacturing landscape in France, Germany, Italy, Ireland, Switzerland, the UK, and the Nordic countries.
  • The European and US outsourcing markets combined represent over half of the global CDMO industry.
  • It was developed in partnership with MassMEDIC, the Massachusetts Medical Device Industry Council, which is the largest regional medtech association in the US and Alira Health’s medtech community partner.

Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report

Retrieved on: 
Monday, February 26, 2024

FRAMINGHAM, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health , a global life sciences advisory and clinical research firm, announced the release of the 2024 Global Medtech Contract Manufacturing Report .

Key Points: 
  • FRAMINGHAM, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health , a global life sciences advisory and clinical research firm, announced the release of the 2024 Global Medtech Contract Manufacturing Report .
  • This report offers a comprehensive analysis of trends in the global medtech contract manufacturing (CDMO) market and includes a deep dive into the contract manufacturing landscape in France, Germany, Italy, Ireland, Switzerland, the UK, and the Nordic countries.
  • The European and US outsourcing markets combined represent over half of the global CDMO industry.
  • It was developed in partnership with MassMEDIC, the Massachusetts Medical Device Industry Council, which is the largest regional medtech association in the US and Alira Health’s medtech community partner.

Standard BioTools to Participate in Upcoming Investor Conferences

Retrieved on: 
Thursday, February 22, 2024

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that management will participate in the following investor conferences:

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that management will participate in the following investor conferences:
    TD Cowen’s 44th Annual Healthcare Conference on Wednesday, March 6, 2024.
  • President and Chief Executive Officer, Michael Egholm, PhD, will present at 1:30 p.m.
  • KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024.
  • Egholm will participate in a fireside chat at 10:30 a.m.